Strontium fructose 1,6-diphosphate alleviates early diabetic testopathy by suppressing abnormal testicular matrix metalloproteinase system in streptozocin-treated rats

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 2, 2009, Pages 229-236

  Zhang, Qi ^a   Liu, Hao Ran ^b   Ying, Han Jie ^a   Dai, De Zai ^b   Tang, Xiao Yun ^b   Dai, Yin ^b  

^a NANJING TECH UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Male hypogonadism; Strontium fructose 1,6 diphosphate; Testopathy; Type 2 diabetes

Indexed keywords

ACID PHOSPHATASE; FRUCTOSE 1,6 BISPHOSPHATE; GAMMA GLUTAMYLTRANSFERASE; GELATINASE A; GELATINASE B; LACTATE DEHYDROGENASE; MESSENGER RNA; STRONTIUM; STRONTIUM FRUCTOSE 1,6 BISPHOSPHATE; SUCCINATE DEHYDROGENASE; TESTOSTERONE; TESTOSTERONE PROPIONATE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; HISTOLOGY; HYPOGONADISM; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; TESTIS; TESTIS DISEASE; TESTOSTERONE BLOOD LEVEL;

EID: 59049086900     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.02.0013     Document Type: Article

References (45)

1. Tenover JL. The androgen-deficient aging male: current treatment options. Rev Urol 2003; 5(Suppl): S22-S28.
2. Hijazi RA et al. Gonadal and erectile dysfunction in diabetics. Med Clin North Am 2004; 88: 933-945, xi.
3. Pitteloud N et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 2005; 90: 2636-2641.
4. Corona G et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res 2006; 18: 190-197.
5. Ballester J et al. Tungstate treatment improves Leydig cell function in streptozotocin-diabetic rats. J Androl 2005; 26: 706-715.
6. Komaki K et al. Gonadal hormones and gonadal function in type 2 diabetes model OLETF (Otsuka Long Evans Tokushima Fatty) rats. Endocr J 2005; 52: 345-351.
7. Cai L et al. Apoptotic germ-cell death and testicular damage in experimental diabetes: prevention by endothelin antagonism. Urol Res 2000; 28: 342-347.
8. Armagan A et al. Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rat testis. Asian J Androl 2006; 8: 595-600.
9. Lazarou S, Morgentaler A. Hypogonadism in the man with erectile dysfunction: what to look for and when to treat. Curr Urol Rep 2005; 6: 476-481.
10. Siu MK, Cheng CY. Dynamic cross-talk between cells and the extracellular matrix in the testis. Bioessays 2004; 26: 978-992.
11. Guyot R et al. Differential expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) during mouse gonad development. Dev Dyn 2003; 227: 357-366.
12. Longin J, Le Magueresse-Battistoni B. Evidence that MMP-2 and TIMP-2 are at play in the FSH-induced changes in Sertoli cells. Mol Cell Endocrinol 2002; 189: 25-35.
13. Slongo ML et al. Expression of matrix metalloproteases (MMP-2, MT1 -MMP) and their tissue inhibitor (TIMP-2) by rat Sertoli cells in culture: implications for spermatogenesis. Biol Chem 2002; 383: 235-239.
14. Cameron DF et al. Interstitial compartment pathology and spermatogenic disruption in testes from impotent diabetic men. Anat Rec 1985; 213: 53-62.
15. Sanguinetti RE et al. Ultrastructural changes in mouse Leydig cells after streptozotocin administration. Exp Anim 1995; 44: 71-73.
16. Zhang JN et al. Protective effect of exogenous fructose-1,6- diphosphate in cardiogenic shock. Cardiovasc Res 1988; 22: 927-932.
17. Feng Y et al. Strontium fructose 1,6-diphosphate rescues adenine-induced male hypogonadism and upregulates the testicular endothelin-1 system. Clin Exp Pharmacol Physiol 2007; 34: 1131-1137.
18. US National Institutes of Health. NIH Publication No. 85-23, revised 1996.
19. Pant N, Srivastava SP. Testicular and spermatotoxic effects of quinalphos in rats. J Appl Toxicol 2003; 23: 271-274.
20. Jana K et al. Effects of chronic exposure to sodium arsenite on hypothalamo-pituitary-testicular activities in adult rats: possible an estrogenic mode of action. Reprod Biol Endocrinol 2006; 4: 9.
21. Tang X et al. Effects of CPU 86017 (chlorobenzyltetrahydro- berberine chloride) and its enantiomers on thyrotoxicosis- induced overactive endothelin-1 system and oxidative stress in rat testes. Urology 2006; 68: 455-461.
22. Gerhards S et al. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 2001; 57: 675-679.
23. Qi MY et al. A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up- regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats. J Cardiovasc Pharmacol 2006; 47: 729-735.
24. Arias WM et al. Expression of lactate dehydrogenases A and B during chicken spermatogenesis: characterization of testis specific transcripts. J Cell Biochem 2000; 79: 15-27.
25. Kobayashi T et al. Localization and physiological implication of aldose reductase and sorbitol dehydrogenase in reproductive tracts and spermatozoa of male rats. J Androl 2002; 23: 674-683.
26. Seligman J et al. Nonprotein thiols and disulfides in rat epididymal spermatozoa and epididymal fluid: role of gamma- glutamyl- transpeptidase in sperm maturation. J Androl 2005; 26: 629-637.
27. Chemes H. The phagocytic function of Sertoli cells: a morphological, biochemical, and endocrinological study of lysosomes and acid phosphatase localization in the rat testis. Endocrinology 1986; 119: 1673-1681.
28. Tang XY et al. Effects of strontium fructose 1,6-diphosphate on expression of apoptosis-related genes and oxidative stress in testes of diabetic rats. Int J Urol 2008; 15(3): 251-256.
29. Mallidis C et al. Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus. Hum Reprod 2007; 22(8): 2169-2177.
30. Zhang XH et al. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med 2006; 3: 253-264.
31. Nagase H et al. Structure and function of matrix metallopro- teinases and TIMPs. Cardiovasc Res 2006; 69: 562-573.
32. Longin J et al. MT1-MMP in rat testicular development and the control of Sertoli cell proMMP-2 activation. J Cell Sci 2001; 114: 2125-2134.
33. Setchell BP et al. Postnatal testicular development, cellular organization and paracrine regulation. EndocrDev 2003; 5:24-37.
34. Huleihel M, Lunenfeld E. Regulation of spermatogenesis by paracrine/autocrine testicular factors. Asian J Androl 2004; 6: 259-268.
35. Markov AK et al. Increasing survival of dogs subjected to hemorrhagic shock by administration of fructose 1-6 diphosphate. Surgery 1987; 102: 515-527.
36. Ahn SM et al. Fructose 1,6-diphosphate alleviates UV-induced oxidative skin damage in hairless mice. Biol Pharm Bull 2007; 30: 692-697.
37. Newsholme P et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 2007; 583(Pt 1): 9-24.
38. De la Monte SM, Wands JR. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Ahheimers Dis 2006; 9(2): 167-181.
39. Anon. Oxidative stress in human diseases. Srp Arh Celok Lek 2008; 136(Suppl 2): 158-165.
40. Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008; 454: 455-462.
41. Miner MM, Sadovsky R. Evolving issues in male hypogonadism: evaluation, management, and related comorbidities. Cleve Clin J Med 2007; 74(Suppl 3): S38-S46.
42. Beg S et al. Testosterone replacement in men. Curr Opin Endocrinol Diabetes Obes 2008; 15: 364-370.
43. Lunenfeld B. Androgen therapy in the aging male. World J Urol 2003; 21: 292-305.
44. Srinivas-Shankar U, Wu FC. Drug insight: testosterone preparations. Nat Clin Pract Urol 2006; 3: 653-665.
45. Blake GM, Fogelman I. Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy. Clin Interv Aging 2006; 1(4): 367-375.